References
- Willison H, Jacobs B, Doorn P. Guillain-Barré syndrome. Lancet. 2016;388:717-727.
- McGrogan A, Madle G, Seaman H, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32:150-163.
- Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469-482.
- Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012;366:2294-2304.
- Cortese A, Baldanti F, Tavazzi E, et al. Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature. J Neurol Sci. 2012;312:173-176.
- Hahn A F. Guillain-Barre syndrome. Lancet. 1998;352:635641.
- Muhammad W, Qaseem A, Amray A. Post Vaccination Guillain Barre Syndrome: A Case Report. Cureus. 2018;10: e2511.
- Salmon D, Proschan M, Forshee R, et al. Association between Guillain-Barré syndrome and influenza A (H1N1)2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013;381:1461-1468.
- Sejvar J, Baughman A, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36:123-133.
- Hafer-Macko C, Hsieh ST, Ho WT, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol. 1996;40:635-644.
- Khatib H, Naous A, Ghanem S, Dbaibo G, Rajab M. Case report: Guillain-Barre syndrome with pneumococcus - A new association in pediatrics. IDCases. 2017;11:36-38.
- Li-Syue L, Chung C, Wu Y, et al. Epidemiology and prognostic factors of inpatient mortality of Guillain-Barré syndrome: A nationwide population study over 14 years in Asian country. J Neurol Sci. 2016;369:159-164.
- Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70:1608-1613.
- Ruiz E, Ramalle-Gomara E, Quinones C, Martínez-Ochoa E. Trends in Guillain-Barré syndrome mortality in Spain from 1999 to 2013. Int J Neurosci. 2016;126:985-988.
- Stoian A, Motataianu A, Bajko Z, Balasa A. Guillain–Barré and Acute Transverse Myelitis Overlap Syndrome Following Obstetric Surgery. JCCM. 2020;6:74-79.
- Van der Berg B, Bunschoten C, A van Doorn P, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013;80:1650-1654.
- Yamana M, Kuwahara M, Fukumoto Y, Yoshikawa K, Takada K, Kusunoki S. Guillain-Barré syndrome and related diseases after influenza virus infection. Neurol Neuroimmunol Neuroinflamm. 2019;6:e575.
- Tripp A. Acute transverse myelitis and Guillain-Barre overlap syndrome following influenza infection. CNS Spectr. 2008;13(9):744-746.
- Uncini A, Kuwabara S. Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry. 2015;86:1186-1195.
- Zhang Li C, Po Lai Ho, Kintner D, Sun D, Chiu SY. Activity-Dependent Regulation of Mitochondrial Motility by Calcium and Na/K-ATPase at Nodes of Ranvier of Myelinated Nerves. J Neurosci. 2010;30:3555-3566.
- Simpson B, Rajabally Y. Sensori‐motor Guillain‐Barré syndrome with anti‐GD1b antibodies following influenza A infection. Eur J Neurol. 2009;16:e81.
- Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012;123:1487-1495.
- Kaida K. Guillain-Barre syndrome. Adv Exp Med Biol. 2019;1190:323-331.
- Park S, Pai K, Kim J, Shin JII. The role of interleukin 6 in the pathogenesis of hyponatremia associated with Guillain-Barré syndrome. Nefrologia. 2012;32:114.
- Press R, Ozenci V, Kouwenhoven M, Link H. Non-TH1 cytokines are augmented systematically early in Guillain-Barre syndrome. Neurology. 2002;58:476-478.
- Netto AB, Taly AB, Kulkarni GB, Uma Maheshwara Rao GS, Rao S. Complications in mechanically ventilated patients of Guillain–Barre syndrome and their prognostic value. J Neurosci Rural Pract. 2017;8:68–73.
- Kutlesa M, Santini M, Krajinovic V, Raffanelli D, Barsić B. Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection. Neurocrit Care. 2010;13:98-100.
- Tam C, O’Brien S, Petersen I, Islam A, Hayward A, Rodrigues LC. Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One. 2007;2:e344.
- Winer JB. Guillain-Barré syndrome: clinical variants and their pathogenesis. J Neuroimmunol. 2011;231:70-72.
- Verity C, Stellitano L, Winstone A, Andrews N, Stowe J, Miller E. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children. Lancet. 2011;378:1545-1546.
- Liu S, Dong C, Ubogu E. Immunotherapy of Guillain-Barré syndrome. Hum Vaccin Immunother. 2018;14:2568-2579.
- Stoian A, Motataianu A, Barcutean L, et al. Understanding the mechanism of action of intravenous immunoglobulins: a ten years’ experience in treating Guillain Barré syndrome. Farmacia. 2020;68:3.
- Hughes R, Swan A, Raphaël JC, Annane D, van Konigsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain. 2007;130:2245-2257.